Tobacco Defensin NaD1's Effects on Candida albicans
Author Information
Author(s): Shevchenko Olga V., Voropaev Alexander D., Bogdanov Ivan V., Ovchinnikova Tatiana V., Finkina Ekaterina I.
Primary Institution: M.M. Shemyakin and Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences
Hypothesis
NaD1 might affect the development of candidiasis in vivo, including that caused by resistant fungal strains.
Conclusion
The tobacco defensin NaD1 is effective against both susceptible and resistant strains of Candida albicans and can enhance the effects of other antifungal agents.
Supporting Evidence
- NaD1 was equally effective and fungicidal against all tested strains of C. albicans.
- NaD1 inhibited the adhesion of C. albicans cells to the human epithelium.
- NaD1 enhanced the antibiofilm activity of caspofungin.
Takeaway
NaD1 is like a superhero for fighting off bad fungi that can make us sick, even the ones that are tough to beat.
Methodology
The study involved testing NaD1's antifungal activity against various strains of Candida albicans using microdilution methods and assessing its effects on adhesion and biofilm formation.
Limitations
The study did not investigate the expression of virulence genes and toxin production by different strains of C. albicans.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website